Keyphrases
Insulin-like
100%
Insulin-like Growth Factor 1 Receptor (IGF1R)
81%
Growth Factors
40%
Insulin Receptor
34%
Breast Cancer
30%
Growth Hormone Receptor
30%
Breast Cancer Cells
23%
Maltose-binding Protein
22%
Growth Factor Signaling
22%
Aspartic Protease
21%
Procathepsin D
17%
Cancer Metastasis
17%
Metastatic Breast Cancer
17%
Cancer Cells
17%
Breast Cancer Treatment
17%
ScFv-Fc
16%
Clinical Trials
16%
Humanized
16%
Single-chain Antibody
15%
Metastasis
15%
Pepsinogen
15%
MCF-7 Cells
12%
Cancer Therapy
12%
Escherichia Coli
11%
Cancer Treatment
10%
Inclusion Bodies
10%
Breast Tumor
10%
Motility
10%
Receptor Downregulation
10%
IGF Signaling
9%
Cell-derived
9%
Insulin-like Growth Factor 2 (IGF2)
9%
Human Antibody
8%
Mouse Model
8%
Metastatic Lesions
8%
Dominant Negative
8%
Receptor Expression
8%
In Cancer
8%
Factor System
8%
Tumor Cells
8%
Lung
8%
Tumor Growth
8%
EMT Reversal
7%
Chimeric Antigen Receptor T Cells (CAR-T)
7%
IRS2
7%
Signal Transduction Inhibitors
7%
Chemotherapy Response
7%
Inhibition of Cancer Cell Proliferation
7%
Quantum Dots
7%
Sarcoma
7%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
71%
Somatomedin C Receptor
53%
Malignant Neoplasm
48%
Somatomedin
40%
Insulin Receptor
34%
Somatomedin C
28%
Neoplasm
23%
Somatomedin Receptor
22%
Receptor
20%
Tumor Growth
19%
Metastasis
18%
Clinical Trial
18%
Single Chain Fragment Variable Antibody
17%
Tamoxifen
15%
Pepsinogen
11%
Primary Tumor
10%
Aspartic Proteinase
9%
Mouse Model
9%
Chemotherapy
9%
Quantum Dot
7%
Doxorubicin
7%
Antibody Conjugate
7%
Triple Negative Breast Cancer
7%
Perlecan
7%
Breast Tumor
7%
Maltose Binding Protein
7%
Fibroblast Growth Factor
7%
Thioredoxin
7%
Calcium Ion
7%
Immunogenicity
7%
Interleukin 4 Receptor
7%
Gamma Urogastrone
7%
Breast Carcinoma
7%
Cancer Growth
5%
Hyperinsulinemia
5%
Ave 1642
5%
Medicine and Dentistry
Breast Cancer
54%
Metastatic Carcinoma
25%
Cancer Cell
25%
Somatomedin
22%
Somatomedin Receptor
15%
Receptor
13%
Cancer Therapy
10%
Cell Proliferation
10%
In Vitro
9%
Insulin Receptor
8%
Receptor Expression
8%
Somatomedin C
8%
down Regulation
8%
Lung
8%
Receptor down Regulation
7%
Magnetic Resonance Imaging
7%
Osteoclast Activity
7%
Fibroblast Growth Factor
7%
Chimeric Antigen Receptor T-Cell
7%
Perlecan
7%
Antibody Conjugate
7%
Triple Negative Breast Cancer
7%
Doxorubicin
7%
Chemotherapy
7%
Quantum Dot
7%
Connective Tissue Cancer
7%
Tumor Cell
6%
Clinical Trial
6%
Somatomedin C Receptor
5%